Skip to main content

Morning Bell 11 December

Jessica Amir
December 11, 2020

The ASX200 is eyeing a fall of 0.5% at the open.

CSL and the University of Queensland have abandoned their COVID-19 vaccine trial, as the risk of failure was too high.

House Speaker Nancy Pelosi said bipartisan negotiations were leading to “great progress”, but both sides were still debating over a liability waiver for businesses, leading to no progress on new U.S. stimulus.

U.S. unemployment claims rose more than expected last week, with jobless claims jumping to 800,000, the highest level since October.

The Iron price jumped to US$151 per tonne after rising 3%, collectively gaining 63% this year.

What to watch today:

  • Expect CSL (ASX:CSL) to see a pull back today and to fall under $300. Keep in mind the potential COVID-19 vaccine was not a revenue stream for the business as they are the biggest blood therapy business in the world, and number two in flu shots. Once restrictions ease, blood plasma collections are expected to pick up again, hence why UBS has a $346 price target for CSL and Credit Suisse targets $325.
  • Pendal (ASX:PDL) and Westpac (ASX:WBC) will hold their AGMs today.

Local trading ideas:

  • Baby Bunting (ASX:BBN) was reiterated as a Citi buy with a $5.48 price target.
  • Beach Energy (ASX:BPT) was initiated as a Bell Potter buy with a $2.29 target, implying 24% upside in a year from yesterday’s close.
  • NEXTDC (ASX:NXT), Breville (ASX:BRG) and Enero Group (ASX:EGG) are all showing bullish charting signals according to Trading Central.

Market Update

Julia Lee
December 3, 2018

Market Update

Julia Lee
November 30, 2018

Market Update 28 Nov

Julia Lee
November 29, 2018

November Market Overview

Julia Lee
November 29, 2018

The Spectrum Strategic Income Fund

Bell Direct
November 6, 2018

The Schroder Fixed Income Fund

Bell Direct
November 6, 2018

The Schroder Absolute Return Income Fund

Bell Direct
November 6, 2018

Market Update

Julia Lee
September 21, 2018

Equity Investor 17 September

Julia Lee
September 18, 2018

Equity Investor 10 September

Julia Lee
September 11, 2018

Equity Investor 3 September

Julia Lee
September 4, 2018